REQUEST A DEMO
Total
USD $0.00
Search more companies

Ambee Pharmaceuticals Ltd (Bangladesh)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ambee Pharmaceuticals Ltd Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ambee Pharmaceuticals Ltd is a fast-growing company that was established in 1976 in Dhaka, Bangladesh. It is a public limited company registered under the Companies Act, 1913. Ambee has a joint venture with the multinational company Medimpex of Hungary. The company started with 17 joint ventured products and now offers a total of 76 products, including tablets, capsules, liquids, gels in tubes, and injectables. Ambee operates throughout Bangladesh with a large number of field forces to establish product demand across the country. The company has four outside depots located in Khulna, Bogra, Chittagong, and Sylhet, in addition to its National Distribution Cell in Dhaka. Since its launch in 1976, Ambee Pharmaceuticals has grown significantly. In its first year, the company had 30 field forces and 17 products, generating sales of over 1 Crore. As of 2001, Ambee offers 68 products in various forms. The company has its own distribution network with five depots and over 150 employees in the Distribution Department. The sales team has grown to 200 people in the field. Ambee has also successfully explored the export market, completing an export deal with Myanmar in 2000 and working towards similar opportunities in African and SAARC countries. Ambee Pharmaceuticals PLC is committed to achieving business excellence through quality and customer satisfaction. The company follows a Quality Management System to ensure consistent product quality and meets all national regulatory requirements. It also adheres to Good Manufacturing Practices recommended by the World Health Organization. The management of Ambee Pharmaceuticals PLC is dedicated to maintaining quality standards, and all employees follow documented procedures for quality assurance. The company is ISO 9001 certified, which recognizes its quality management system's compliance with international standards. Ambee Pharmaceuticals PLC engages in the marketing, sales, and distribution of antibiotics, anti-ulcerants, psychotropics, vitamins, and antacids in various forms. The company's headquarters is located in Dhaka, Bangladesh.

Legal Address
184/1, Tejgaon Industrial Area Dhaka-1208
Dhaka; Dhaka; Postal Code: 1208

Contact Details: Purchase the Ambee Pharmaceuticals Ltd report to view the information.

Website: http://www.ambeepharma.com

Basic Information
Total Employees:
Purchase the Ambee Pharmaceuticals Ltd report to view the information.
Outstanding Shares:
Purchase the Ambee Pharmaceuticals Ltd report to view the information.
Registered Capital:
Purchase the Ambee Pharmaceuticals Ltd report to view the information.
Financial Auditors:
Purchase the Ambee Pharmaceuticals Ltd report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
17.32%
Purchase this report to view the information.
5.43%
Company Performance
Financial values in the chart are available after Ambee Pharmaceuticals Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.
Net sales revenue
10.56%
Total operating revenue
10.56%
Operating profit (EBIT)
-10.35%
EBITDA
6.45%
Net Profit (Loss) for the Period
98.29%
Total assets
9.45%
Total equity
-56.26%
Operating Profit Margin (ROS)
-0.76%
Net Profit Margin
1.1%
Return on Equity (ROE)
9.98%
Debt to Equity Ratio
597.78%
Quick Ratio
-0.01%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?